Allosteric Modulation of the Dopamine D2 Receptor by Pro-Leu-Gly-NH2 Peptidomimetics Constrained in Either a Polyproline II Helix or a Type II β-Turn Conformation

详细信息    查看全文

• 作者：Bhooma Raghavan^† ; ; Kevin J. Skoblenick^‡ ; ; Swapna Bhagwanth^† ; ; Niran Argintaru^‡ ; ; Ram K. Mishra^‡ ; ; Rodney L. Johnson*
• 刊名：Journal of Medicinal Chemistry
• 出版年：2009
• 出版时间：April 9, 2009
• 年：2009
• 卷：52
• 期：7
• 页码：2043-2051
• 全文大小：265K
• 年卷期：v.52,no.7(April 9, 2009)
• ISSN：1520-4804

文摘

Type II β-turn mimics and polyproline II helix mimics based upon diastereoisomeric 5.6.5 spiro bicyclic scaffolds have provided two pairs of Pro-Leu-Gly-NH₂ (PLG) peptidomimetics with contrasting dopamine receptor modulating activities. Compounds 1a and 3a were found to be positive allosteric modulators of the dopamine receptor, while the corresponding diastereoisomeric compounds 1b and 3b provided the first PLG peptidomimetics with the ability to decrease the binding of agonists to the dopamine receptor. The positive allosteric modulating activity of 3a supported the hypothesis that a polyproline II helix conformation is the bioactive conformation for the PLG analogue Pro-Pro-Pro-NH₂. The results also show that a change in the bridgehead chirality of the 5.6.5 scaffold brings about opposite effects in terms of the modulation of the dopamine receptor.